Research progress in the diagnosis, treatment, and prognosis of metastatic uveal melanoma
10.3760/cma.j.cn115989-20230808-00062
- VernacularTitle:转移性葡萄膜黑色素瘤诊疗及预后研究进展
- Author:
Jinhai YU
1
;
Yaohua WANG
;
Hongfei LIAO
Author Information
1. 南昌大学附属眼科医院，南昌 330006
- Publication Type:Journal Article
- Keywords:
Metastatic uveal melanoma;
Immune checkpoint inhibitors;
Clinical trials
- From:
Chinese Journal of Experimental Ophthalmology
2025;43(9):846-851
- CountryChina
- Language:Chinese
-
Abstract:
Metastatic uveal melanoma (MUM) is a rare but highly invasive ocular malignant tumor with poor prognosis.At present, there is a lack of standardized methods for the treatment of MUM, resulting in poor prognosis.However, in recent years, the emergence of immune checkpoint inhibitors, new immune drug Tebenfos, comprehensive targeted therapy, combined sequential therapy and other treatment methods has brought new hope to MUM patients.This review aims to summarize the latest progress in the diagnosis, treatment, and prognosis of MUM.
